Clinical Research Directory
Browse clinical research sites, groups, and studies.
Antisecretory Factor In Severe Traumatic Brain Injury
Sponsor: Peter Siesjö
Summary
This study evaluates the addition of Salovum, an egg yolk powder enriched for antisecretory factor, to standard care of participants with severe traumatic brain injury. Half of the participants will be administered Salovum while the other half will be given a placebo egg yolk powder, not enriched for antisecretory factor. Intracranial pressure (ICP), partial brain oxygen pressure (PtbO2), microdialysis of metabolites and inflammatory mediators and trauma intensity level (TIL) will be assessed in all patients.
Official title: Evaluation of Antisecretory Factor in Treatment of Severe Traumatic Brain Injury With Multimodal Monitoring
Key Details
Gender
All
Age Range
10 Years - 70 Years
Study Type
INTERVENTIONAL
Enrollment
20
Start Date
2020-03-10
Completion Date
2027-06-30
Last Updated
2026-01-21
Healthy Volunteers
No
Conditions
Interventions
Salovum
Active egg yolk powder
Placebo egg yolk powder
Normal egg yolk powder
Locations (1)
Skane University Hopsital
Lund, Sweden